Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006

被引:26
作者
Chung, Gyungtae [1 ]
Cha, Jeongok [1 ]
Han, Sunyoung [1 ]
Jang, Heesun [1 ]
Lee, Kyeongmin [1 ]
Yoo, Jaeil [1 ]
Yoo, Jeongsik [1 ]
Kim, Hongbin [2 ]
Eun, Soohoon [1 ]
Kim, Bongsu [1 ]
Park, Ok [3 ]
Lee, Yeong Seon [1 ]
机构
[1] NIH, Div Antimicrobial Resistance, Ctr Infect Dis, Seoul 122701, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea
[3] Korea Ctr Dis Control & Prevent, Infectious Dis Surveillance Team, Seoul 122701, South Korea
关键词
Staphylococcus aureus; surveillance; vancomycin-intermediate; REDUCED SUSCEPTIBILITY; MULTIPLEX PCR; HETEROGENEOUSLY RESISTANT; TOXIN GENES; GLYCOPEPTIDES; EMERGENCE; IDENTIFICATION; MICHIGAN; PATIENT;
D O I
10.4014/jmb.0906.06018
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We investigated the prevalence and the molecular characteristics of vancomycin-intermediate Staphylococcus aureus (VISA) among methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 8-week period in each year from 2001 to 2006. Of 41,639 MRSAs isolated, 37,856 were screened and 169 grew on brain heart infusion agar supplemented with 4 mu g/ml vancomycin. A vancomycin MIC of 4 mu g/ml was confirmed for 33 VISA isolates of the 169 isolates. Eighteen of the 33 isolates were classified as hetero-VISA (hVISA) by the population analysis profile (PAP) method. All VISA isolates were susceptible to linezolid, tigecycline, and quinupristin dalfopristin. Most VISA isolates (MIC 4 mu g/ml) showed a PFGE C pattern with sec, seg, and sei enterotoxin genes, including ST5-SCCmec type II, or a PFGE A pattern with sea, including ST239-SCCmec type III.
引用
收藏
页码:637 / 642
页数:6
相关论文
共 38 条
[1]   Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini hospital in Tehran [J].
Aligholi, Marzieh ;
Emaneini, Mohammad ;
Jabalameli, Fereshteh ;
Shahsavan, Shadi ;
Dabiri, Hosein ;
Sedaght, Hossein .
MEDICAL PRINCIPLES AND PRACTICE, 2008, 17 (05) :432-434
[2]  
[Anonymous], 2012, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard
[3]   Rapid and specific detection of toxigenic Staphylococcus aureus:: Use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene [J].
Becker, K ;
Roth, R ;
Peters, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2548-2553
[4]   Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany [J].
Bierbaum, G ;
Fuchs, K ;
Lenz, W ;
Szekat, C ;
Sahl, HG .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) :691-696
[5]  
*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1165
[6]   CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS [J].
CLARK, NC ;
COOKSEY, RC ;
HILL, BC ;
SWENSON, JM ;
TENOVER, FC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2311-2317
[7]   Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus [J].
Cui, LZ ;
Tominaga, E ;
Neoh, HM ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :1079-1082
[8]   Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital:: microbiological and clinical features [J].
Denis, O ;
Nonhoff, C ;
Byl, B ;
Knoop, C ;
Bobin-Dubreux, S ;
Struelens, MJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) :383-391
[9]   Vancomycin-Resistant Staphylococcus aureus, Michigan, USA, 2007 [J].
Finks, Jennie ;
Wells, Eden ;
Dyke, Teri Lee ;
Husain, Nasir ;
Plizga, Linda ;
Heddurshetti, Renuka ;
Wilkins, Melinda ;
Rudrik, James ;
Hageman, Jeffrey ;
Patel, Jean ;
Miller, Corinne .
EMERGING INFECTIOUS DISEASES, 2009, 15 (06) :943-945
[10]   The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus [J].
Goldstein, F. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) :1-4